TPG Capital To Buy Thycotic For $1.4B, Merge It With Rival Centrify: Report
TPG Capital To Buy Thycotic For $1.4B, Merge It With Rival Centrify: Report The deal between TPG and privileged access management vendor Thycotic was signed Monday but has yet to close. It will lead to the private equity firm combining Thycotic with recently acquired rival Centrify. By Michael Novinson March 02, 2021, 11:19 AM EST TPG Capital has agreed to purchase privileged access management (PAM) vendor Thycotic for $1.4 billion and combine it with recently acquired competitor Centrify, PE Hub reported. The deal between San Francisco-based TPG and Washing...
Source: crn.com